Peer Review reports
From: High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer
| Original Submission | ||
|---|---|---|
| 24 Nov 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 21 Dec 2021 | Reviewed | Reviewer Report - Fuyuhiko Motoi |
| 29 Dec 2021 | Reviewed | Reviewer Report |
| 17 Jan 2022 | Author responded | Author comments - Johan Bourghardt Fagman |
| Resubmission - Version 3 | ||
| 17 Jan 2022 | Submitted | Manuscript version 3 |
| 26 Jan 2022 | Author responded | Author comments - Johan Bourghardt Fagman |
| Resubmission - Version 4 | ||
| 26 Jan 2022 | Submitted | Manuscript version 4 |
| 16 Mar 2022 | Reviewed | Reviewer Report - Fuyuhiko Motoi |
| 16 Mar 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 28 Mar 2022 | Editorially accepted | |
| 30 Mar 2022 | Article published | 10.1186/s12885-022-09468-6 |
You can find further information about peer review here.